September 17th, 2010
Podcast 101: Osteoarthritis, chondroitin, and glucosamine — one of these things doesn’t belong.
Audio Player
Podcast: Play in new window | Download
Subscribe: RSS
Answer: Osteoarthritis. Two are nostrums and the other is a disease, but the nostrums have no appreciable effect — on osteoarthritis at least. We discuss a BMJ meta-analysis that uses novel methods to prove the point.
The good news is that neither chondroitin nor glucosamine is dangerous, but the bad news is that we spend so much hoping that this is the right combination to alleviate arthritic pain.
Interview related link:
News-related links:
- PSA screening overdiagnoses prostate cancer and doesn’t lower mortality
- A distinct phenotype of chronic obstructive pulmonary disease
- New resistance factor, NDM-1, shows up in North America
Categories: Audio, Chondroitin, glucosamine, Osteoarthritis, pain, Uncategorized
Tags: antibiotic resistance, Chondroitin, chronic obstructive pulmonary disease, COPD, glucosamine, meta-analysis, NDM-1, Osteoarthritis, pain, Peter Juni, prostate screening, PSA, Sven Trelle
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
Comments are closed.

About the Podcast
Comments, suggestions, and story ideas welcome. Learn more about Clinical Conversations.
Subscribe to Clinical Conversations via Email
Archives
-
Recent Posts
- Podcast 298: COPD exacerbations — 7 days of antibiotics versus 2
- Podcast 301: Monkeypox — what to look for, how to treat
- Podcast 300: NADIM II trial offers “quite exciting” results in lung cancer
- Podcast 299: Lung cancer and atezolizumab — results from the IMpower010 trial
- Podcast 297: Forget about all that vitamin D testing!!
- Podcast 296: A roundtable on the question, Why are young internists flocking to the hospitalist practice style?
- Podcast 295: How should clinicians manage severe (but asymptomatic) carotid artery stenosis while awaiting CREST-2’s results?
- Podcast 294: PD-1 blockade in locally advanced rectal cancer
- Podcast 293: HER2-“low” breast cancer and its reponse to an antibody-drug conjugate
- Podcast 292: Informed consent and apnea testing for death — or — What is death, anyway?
-
Tag Cloud
- 2009 H1N1 acute coronary syndromes aspirin asthma blood pressure breast cancer cancer risk cardiovascular disease Cardiovascular risk COPD coronary heart disease dabigatran dementia depression diabetes Diabetes type 2 diet Elderly Emergency medicine epidemiology falls FDA glucose guidelines H1N1 Heart failure hypertension influenza pain Patient care patients pregnancy Prostate cancer prostate screening proton pump inhibitors PSA Quality of care risk Rivaroxaban screening smoking stents stroke vaccination warfarin